A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS.
Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5.
A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders.
Kim S, Rush BS, Rice TR.
Eur Child Adolesc Psychiatry. 2021 Oct;30(10):1485-1501. doi: 10.1007/s00787-020-01542-3. Epub 2020 May 8.
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Conway CR, Aaronson ST, Sackeim HA, George MS, Zajecka J, Bunker MT, Duffy W, Stedman M, Riva-Posse P, Allen RM, Quevedo J, Berger M, Alva G, Malik MA, Dunner DL, Cichowicz I, Banov M, Manu L, Nahas Z, Macaluso M, Mickey BJ, Sheline Y, Kriedt CL, Lee YL, Gordon C, Shy O, Tran Q, Yates L, Rush AJ.
Brain Stimul. 2024 Dec 18;18(3):676-689. doi: 10.1016/j.brs.2024.12.1191. Online ahead of print.
Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial.
Coenen VA, Bewernick BH, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein ME, Spanier S, Sajonz B, Urbach H, Schlaepfer TE.
Neuropsychopharmacology. 2019 Jun;44(7):1224-1232. doi: 10.1038/s41386-019-0369-9. Epub 2019 Mar 13.
A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD).
Ng CG, Abousheishaa AA, Low SY, Zainal NZ, Thong KS, Awaluddin AB, Loo TH, Yacob SB, Nik Jaafar NR, Abdul Taib NIA, Mohamad Kamal NAB, Ismail F, Zamaniah Wi W.
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2583-2591. doi: 10.31557/APJCP.2023.24.8.2583.
Traditional Chinese Acupuncture for Poststroke Depression: A Single-Blind Double-Simulated Randomized Controlled Trial.
Qian X, Zhou X, You Y, Shu S, Fang F, Huang S, Zhou S.
J Altern Complement Med. 2015 Dec;21(12):748-53. doi: 10.1089/acm.2015.0084. Epub 2015 Sep 18.
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr.
J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, Aitchison KJ, Rietschel M.
World J Biol Psychiatry. 2011 Oct;12(7):528-38. doi: 10.3109/15622975.2011.559270. Epub 2011 Mar 9.
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset.
Pulido CM, Walson IS, Yang A, Stika CS, Sit DK, Wisner KL.
J Clin Psychopharmacol. 2025 Mar-Apr 01;45(2):106-110. doi: 10.1097/JCP.0000000000001928. Epub 2024 Dec 4.
Clinical research on the therapeutic effect of the electro-acupuncture treatment in patients with depression.
Luo H, Meng F, Jia Y, Zhao X.
Psychiatry Clin Neurosci. 1998 Dec;52 Suppl:S338-40. doi: 10.1111/j.1440-1819.1998.tb03262.x.
